Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
Miles A. Miller(Harvard University), Ralph Weissleder(Massachusetts General Hospital), Gregory R. Wojtkiewicz(Harvard University), Ashley M. Laughney(Cornell University), Sushma Bhonagiri(Brigham and Women's Hospital), Nazila Kamaly(Imperial College London), Omid C. Farokhzad(Brigham and Women's Hospital), Christina Pfirschke(Harvard University), Katherine S. Yang(Bioanalytica (Switzerland)), Suresh Gadde(University of Ottawa), Camilla Engblom(Karolinska Institutet), Mikaël J. Pittet(University of Geneva), Melissa M. Sprachman(Harvard University), Rainer H. Köhler(Massachusetts General Hospital)
Cited by 333
Related Papers
Cancer nanomedicine: progress, challenges and opportunities
|Nature reviews. Cancer|2016|5.6k
A clearer vision for in vivo imaging
|Nature Biotechnology|2001|3.8k
Imaging in the era of molecular oncology
|Nature|2008|2.3k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
|The Journal of Experimental Medicine|2007|2.3k